{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:07:27Z","timestamp":1767773247612,"version":"3.41.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T00:00:00Z","timestamp":1470268800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Portuguese Foundation for Science and Technology","award":["SFRH\/BD\/52290\/2013","UID\/NEU\/04539\/2013"],"award-info":[{"award-number":["SFRH\/BD\/52290\/2013","UID\/NEU\/04539\/2013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s13402-016-0293-5","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T14:39:49Z","timestamp":1470321589000},"page":"573-582","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["WT1, MSH6, GATA5 and PAX5 as epigenetic oral squamous cell carcinoma biomarkers - a short report"],"prefix":"10.1007","volume":"39","author":[{"given":"Ilda Patr\u00edcia","family":"Ribeiro","sequence":"first","affiliation":[]},{"given":"Francisco","family":"Caramelo","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"Marques","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Domingues","sequence":"additional","affiliation":[]},{"given":"Margarida","family":"Mesquita","sequence":"additional","affiliation":[]},{"given":"Leonor","family":"Barroso","sequence":"additional","affiliation":[]},{"given":"Hugo","family":"Prazeres","sequence":"additional","affiliation":[]},{"given":"Maria Jos\u00e9","family":"Juli\u00e3o","sequence":"additional","affiliation":[]},{"given":"Isabel Poiares","family":"Baptista","sequence":"additional","affiliation":[]},{"given":"Artur","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Joana Barbosa","family":"Melo","sequence":"additional","affiliation":[]},{"given":"Isabel Marques","family":"Carreira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,8,4]]},"reference":[{"key":"293_CR1","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ejca.2015.01.060","volume":"51","author":"LM Arantes","year":"2015","unstructured":"L. M. Arantes, A. C. de Carvalho, M. E. Melendez, C. C. Centrone, J. F. Gois-Filho, T. N. Toporcov, D. N. Caly, E. H. Tajara, E. M. Goloni-Bertollo, A. L. Carvalho, And Gencapo, validation of methylation markers for diagnosis of oral cavity cancer. Eur. J. Cancer 51, 632\u2013641 (2015). doi: 10.1016\/j.ejca.2015.01.060","journal-title":"Eur. J. Cancer"},{"key":"293_CR2","doi-asserted-by":"publisher","unstructured":"A.K. Markopoulos, Current aspects on oral squamous cell carcinoma. Open Dent. J. 6, 126\u2013130 (2012) doi: 10.2174\/1874210601206010126","DOI":"10.2174\/1874210601206010126"},{"key":"293_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s13402-014-0188-2","volume":"37","author":"C Salazar","year":"2014","unstructured":"C. Salazar, R. Nagadia, P. Pandit, J. Cooper-White, N. Banerjee, N. Dimitrova, W. B. Coman, C. Punyadeera, A novel saliva-based microRNA biomarker panel to detect head and neck cancers. Cell. Oncol. 37, 331\u2013338 (2014). doi: 10.1007\/s13402-014-0188-2","journal-title":"Cell. Oncol."},{"key":"293_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s13402-014-0207-3","volume":"37","author":"K Mohankumar","year":"2014","unstructured":"K. Mohankumar, S. Pajaniradje, S. Sridharan, V. K. Singh, L. Ronsard, A. C. Banerjea, B. C. Selvanesan, M. S. Coumar, L. Periyasamy, R. Rajagopalan, Apoptosis induction by an analog of curcumin (BDMC-A) in human laryngeal carcinoma cells through intrinsic and extrinsic pathways. Cell. Oncol. 37, 439\u2013454 (2014). doi: 10.1007\/s13402-014-0207-3","journal-title":"Cell. Oncol."},{"key":"293_CR5","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1634\/theoncologist.2009-0289","volume":"15","author":"D Pulte","year":"2010","unstructured":"D. Pulte, H. Brenner, Changes in survival in head and neck cancers in the late 20th and early twenty-first century: a period analysis. Oncologist 15, 994\u20131001 (2010). doi: 10.1634\/theoncologist.2009-0289","journal-title":"Oncologist"},{"key":"293_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s13402-014-0167-7","volume":"37","author":"T Nakaoka","year":"2014","unstructured":"T. Nakaoka, A. Ota, T. Ono, S. Karnan, H. Konishi, A. Furuhashi, Y. Ohmura, Y. Yamada, Y. Hosokawa, Y. Kazaoka, Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells. Cell. Oncol. 37, 119\u2013129 (2014). doi: 10.1007\/s13402-014-0167-7","journal-title":"Cell. Oncol."},{"key":"293_CR7","doi-asserted-by":"publisher","first-page":"5982","DOI":"10.1158\/0008-5472.CAN-04-0993","volume":"64","author":"Y Tokumaru","year":"2004","unstructured":"Y. Tokumaru, K. Yamashita, M. Osada, S. Nomoto, D. I. Sun, Y. Xiao, M. O. Hoque, W. H. Westra, J. A. Califano, D. Sidransky, Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing. Cancer Res. 64, 5982\u20135987 (2004). doi: 10.1158\/0008-5472.CAN-04-0993","journal-title":"Cancer Res."},{"key":"293_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2982","volume":"11","author":"CR Leemans","year":"2011","unstructured":"C. R. Leemans, B. J. Braakhuis, R. H. Brakenhoff, The molecular biology of head and neck cancer. Nat. Rev. Cancer 11, 9\u201322 (2011). doi: 10.1038\/nrc2982","journal-title":"Nat. Rev. Cancer"},{"key":"293_CR9","first-page":"2108","volume":"26","author":"T Bezabeh","year":"2005","unstructured":"T. Bezabeh, O. Odlum, R. Nason, P. Kerr, D. Sutherland, R. Patel, I. C. Smith, Prediction of treatment response in head and neck cancer by magnetic resonance spectroscopy. AJNR Am. J. Neuroradiol. 26, 2108\u20132113 (2005)","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"293_CR10","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1002\/jmv.21756","volume":"82","author":"RJ Nobre","year":"2010","unstructured":"R. J. Nobre, E. Cruz, O. Real, L. P. de Almeida, T. C. Martins, Characterization of common and rare human papillomaviruses in Portuguese women by the polymerase chain reaction, restriction fragment length polymorphism and sequencing. J. Med. Virol. 82, 1024\u20131032 (2010). doi: 10.1002\/jmv.21756","journal-title":"J. Med. Virol."},{"key":"293_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gni127","volume":"33","author":"AO Nygren","year":"2005","unstructured":"A. O. Nygren, N. Ameziane, H. M. Duarte, R. N. Vijzelaar, Q. Waisfisz, C. J. Hess, J. P. Schouten, A. Errami, Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res. 33, e128 (2005). doi: 10.1093\/nar\/gni127","journal-title":"Nucleic Acids Res."},{"key":"293_CR12","doi-asserted-by":"publisher","first-page":"4687","DOI":"10.1007\/s13277-014-1614-9","volume":"35","author":"IP Ribeiro","year":"2014","unstructured":"I. P. Ribeiro, F. Marques, F. Caramelo, J. Ferrao, H. Prazeres, M. J. Juliao, W. Rifi, S. Savola, J. B. de Melo, I. P. Baptista, I. M. Carreira, Genetic imbalances detected by multiplex ligation-dependent probe amplification in a cohort of patients with oral squamous cell carcinoma-the first step towards clinical personalized medicine. Tumour Biol. 35, 4687\u20134695 (2014). doi: 10.1007\/s13277-014-1614-9","journal-title":"Tumour Biol."},{"key":"293_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s13402-013-0161-5","volume":"37","author":"IP Ribeiro","year":"2014","unstructured":"I. P. Ribeiro, F. Marques, F. Caramelo, J. Pereira, M. Patricio, H. Prazeres, J. Ferrao, M. J. Juliao, M. Castelo-Branco, J. B. de Melo, I. P. Baptista, I. M. Carreira, Genetic gains and losses in oral squamous cell carcinoma: impact on clinical management. Cell. Oncol. 37, 29\u201339 (2014). doi: 10.1007\/s13402-013-0161-5","journal-title":"Cell. Oncol."},{"key":"293_CR14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.14712\/fb2013059020087","volume":"59","author":"M Chmelarova","year":"2013","unstructured":"M. Chmelarova, E. Dvorakova, J. Spacek, J. Laco, M. Mzik, V. Palicka, Promoter methylation of GATA4, WIF1, NTRK1 and other selected tumour suppressor genes in ovarian cancer. Folia Biol. 59, 87\u201392 (2013)","journal-title":"Folia Biol."},{"key":"293_CR15","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.1158\/1078-0432.CCR-03-0370","volume":"10","author":"S Maruya","year":"2004","unstructured":"S. Maruya, J. P. Issa, R. S. Weber, D. I. Rosenthal, J. C. Haviland, R. Lotan, A. K. El-Naggar, Differential methylation status of tumor-associated genes in head and neck squamous carcinoma: incidence and potential implications. Clin. Cancer Res. 10, 3825\u20133830 (2004). doi: 10.1158\/1078-0432.CCR-03-0370","journal-title":"Clin. Cancer Res."},{"key":"293_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/carcin\/bgp220","volume":"31","author":"S Sharma","year":"2010","unstructured":"S. Sharma, T. K. Kelly, P. A. Jones, Epigenetics in cancer. Carcinogenesis 31, 27\u201336 (2010). doi: 10.1093\/carcin\/bgp220","journal-title":"Carcinogenesis"},{"key":"293_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2147\/OTT.S34680","volume":"6","author":"AS Ho","year":"2013","unstructured":"A. S. Ho, S. Turcan, T. A. Chan, Epigenetic therapy: use of agents targeting deacetylation and methylation in cancer management. Onco Targets Ther. 6, 223\u2013232 (2013). doi: 10.2147\/OTT.S34680","journal-title":"Onco Targets Ther."},{"key":"293_CR18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.canlet.2012.02.018","volume":"342","author":"MJ Worsham","year":"2014","unstructured":"M. J. Worsham, J. K. Stephen, K. M. Chen, S. Havard, V. Shah, G. Gardner, V. G. Schweitzer, Delineating an epigenetic continuum in head and neck cancer. Cancer Lett. 342, 178\u2013184 (2014). doi: 10.1016\/j.canlet.2012.02.018","journal-title":"Cancer Lett."},{"key":"293_CR19","doi-asserted-by":"publisher","unstructured":"M. Federico and L. Bagella, Histone deacetylase inhibitors in the treatment of hematological malignancies and solid tumors. J. Biomed. Biotechnol. 2011, 475641 (2011) doi: 10.1155\/2011\/475641","DOI":"10.1155\/2011\/475641"},{"key":"293_CR20","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1349-7006.2003.tb01507.x","volume":"94","author":"Y Oji","year":"2003","unstructured":"Y. Oji, H. Yamamoto, M. Nomura, Y. Nakano, A. Ikeba, S. Nakatsuka, S. Abeno, E. Kiyotoh, T. Jomgeow, M. Sekimoto, R. Nezu, Y. Yoshikawa, Y. Inoue, N. Hosen, M. Kawakami, A. Tsuboi, Y. Oka, H. Ogawa, S. Souda, K. Aozasa, M. Monden, H. Sugiyama, Overexpression of the Wilms\u2019 tumor gene WT1 in colorectal adenocarcinoma. Cancer Sci. 94, 712\u2013717 (2003)","journal-title":"Cancer Sci."},{"key":"293_CR21","doi-asserted-by":"publisher","unstructured":"H. Sugiyama, WT1 (Wilms\u2019 tumor gene 1): biology and cancer immunotherapy. Jpn. J. Clin. Oncol. 40, 377\u2013387 (2010) doi: 10.1093\/jjco\/hyp194","DOI":"10.1093\/jjco\/hyp194"},{"key":"293_CR22","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/sj.leu.2404624","volume":"21","author":"L Yang","year":"2007","unstructured":"L. Yang, Y. Han, F. Suarez Saiz, M. D. Minden, A tumor suppressor and oncogene: the WT1 story. Leukemia 21, 868\u2013876 (2007). doi: 10.1038\/sj.leu.2404624","journal-title":"Leukemia"},{"key":"293_CR23","doi-asserted-by":"publisher","first-page":"8924","DOI":"10.1038\/srep08924","volume":"5","author":"XW Qi","year":"2015","unstructured":"X. W. Qi, F. Zhang, H. Wu, J. L. Liu, B. G. Zong, C. Xu, J. Jiang, Wilms\u2019 tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis. Sci. Rep. 5, 8924 (2015). doi: 10.1038\/srep08924","journal-title":"Sci. Rep."},{"key":"293_CR24","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1158\/1078-0432.CCR-08-3012","volume":"15","author":"S Yip","year":"2009","unstructured":"S. Yip, J. Miao, D. P. Cahill, A. J. Iafrate, K. Aldape, C. L. Nutt, D. N. Louis, MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance. Clin. Cancer Res. 15, 4622\u20134629 (2009). doi: 10.1158\/1078-0432.CCR-08-3012","journal-title":"Clin. Cancer Res."},{"key":"293_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1471-2407-14-101","volume":"14","author":"I Peters","year":"2014","unstructured":"I. Peters, N. Dubrowinskaja, M. Kogosov, M. Abbas, J. Hennenlotter, C. von Klot, A. S. Merseburger, A. Stenzl, R. Scherer, M. A. Kuczyk, J. Serth, Decreased GATA5 mRNA expression associates with CpG island methylation and shortened recurrence-free survival in clear cell renal cell carcinoma. BMC Cancer 14, 101 (2014). doi: 10.1186\/1471-2407-14-101","journal-title":"BMC Cancer"},{"key":"293_CR26","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.3892\/or.2014.3030","volume":"31","author":"I Peters","year":"2014","unstructured":"I. Peters, K. Gebauer, N. Dubrowinskaja, F. Atschekzei, M. W. Kramer, J. Hennenlotter, H. Tezval, M. Abbas, R. Scherer, A. S. Merseburger, A. Stenzl, M. A. Kuczyk, J. Serth, GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma. Oncol. Rep. 31, 1523\u20131530 (2014). doi: 10.3892\/or.2014.3030","journal-title":"Oncol. Rep."},{"key":"293_CR27","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1177\/1947601911404223","volume":"1","author":"R Zheng","year":"2010","unstructured":"R. Zheng, G. A. Blobel, G. A. T. A. Transcription Factors, And cancer. Genes Cancer 1, 1178\u20131188 (2010). doi: 10.1177\/1947601911404223","journal-title":"Genes Cancer"},{"key":"293_CR28","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.4161\/epi.29025","volume":"9","author":"R Guerrero-Preston","year":"2014","unstructured":"R. Guerrero-Preston, C. Michailidi, L. Marchionni, C. R. Pickering, M. J. Frederick, J. N. Myers, S. Yegnasubramanian, T. Hadar, M. G. Noordhuis, V. Zizkova, E. Fertig, N. Agrawal, W. Westra, W. Koch, J. Califano, V. E. Velculescu, D. Sidransky, Key tumor suppressor genes inactivated by \"greater promoter\" methylation and somatic mutations in head and neck cancer. Epigenetics 9, 1031\u20131046 (2014). doi: 10.4161\/epi.29025","journal-title":"Epigenetics"},{"key":"293_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2165\/11635330-000000000-00000","volume":"16","author":"MJ Worsham","year":"2012","unstructured":"M. J. Worsham, H. Ali, J. Dragovic, V. P. Schweitzer, Molecular characterization of head and neck cancer: how close to personalized targeted therapy? Mol. Diagn. Ther. 16, 209\u2013222 (2012). doi: 10.2165\/11635330-000000000-00000","journal-title":"Mol. Diagn. Ther."},{"key":"293_CR30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev.pathol.4.110807.092158","volume":"4","author":"SI Pai","year":"2009","unstructured":"S. I. Pai, W. H. Westra, Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annu. Rev. Pathol. 4, 49\u201370 (2009)","journal-title":"Annu. Rev. Pathol."},{"key":"293_CR31","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/archotol.128.7.751","volume":"128","author":"KT Robbins","year":"2002","unstructured":"K. T. Robbins, G. Clayman, P. A. Levine, J. Medina, R. Sessions, A. Shaha, P. Som, G. T. Wolf, H. American, S. Neck, O.-H. American Academy, Of and S. Neck, neck dissection classification update: revisions proposed by the American head and neck society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch. Otolaryngol. Head Neck Surg. 128, 751\u2013758 (2002)","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"293_CR32","doi-asserted-by":"publisher","unstructured":"Cancer Genome Atlas Network, comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517, 576\u2013582 (2015) doi: 10.1038\/nature14129","DOI":"10.1038\/nature14129"},{"key":"293_CR33","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1200\/JCO.2015.61.2929","volume":"33","author":"SB Chinn","year":"2015","unstructured":"S. B. Chinn, J. N. Myers, Oral cavity carcinoma: current management, controversies, and future directions. J. Clin. Oncol. 33, 3269\u20133276 (2015). doi: 10.1200\/JCO.2015.61.2929","journal-title":"J. Clin. Oncol."}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-016-0293-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13402-016-0293-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-016-0293-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T12:51:29Z","timestamp":1749041489000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13402-016-0293-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,4]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["293"],"URL":"https:\/\/doi.org\/10.1007\/s13402-016-0293-5","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"type":"print","value":"2211-3428"},{"type":"electronic","value":"2211-3436"}],"subject":[],"published":{"date-parts":[[2016,8,4]]}}}